GLG LLC’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

GLG LLC’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-20,979	Closed	-$626K	–	697
2014 Q3	$626K	Buy	+20,979	New	+$445K	0.02%	569

Other funds holding AUXL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GLG LLC's AUXL Position: Q4 2014 in Review

GLG LLC sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 20,979 shares — an estimated $626K sold.

GLG LLC first reported a position in AUXL in Q3 2014 and held it in 1 quarter. The position peaked at $626K in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

GLG LLC reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
GLG LLC sold 20,979 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $626K.
GLG LLC first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2014 and held it in 1 quarter.
GLG LLC's AUXILIUM PHARAMCEUTICALS INC position peaked at $626K in Q3 2014.
158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on GLG LLC's 13F filing for Q4 2014, filed 17 Feb 2015.